1. Challenges in understanding host genetics and severity of community-acquired pneumonia.
- Author
-
Solé-Violán J, Hernández-Brito E, Valencia-Gallardo JM, Herrera-Ramos E, Borderías L, Briones ML, Rajas O, Freixinet J, Lorente L, Payeras A, Ferreres J, Carbonell N, González-Quevedo N, González-Martín JM, Rodríguez de Castro F, and Rodríguez-Gallego C
- Abstract
This study found no association of the top two associated FER variants with severity of community-acquired pneumonia. Precise characterisation of phenotypes may be required in order to unravel the genetic mechanisms predisposing to poor outcome in sepsis. https://bit.ly/3jc9SmR., Competing Interests: Conflict of interest: J. Solé-Violán has nothing to disclose. Conflict of interest: E. Hernández-Brito has nothing to disclose. Conflict of interest: J.M. Valencia-Gallardo has nothing to disclose. Conflict of interest: E. Herrera-Ramos has nothing to disclose. Conflict of interest: L. Borderías reports personal fees, nonfinancial support and other from GSK, personal fees from Allergy Therapeutics, nonfinancial support from Novartis, Boehringer and Esteve Teijin, personal fees from AstraZeneca, and nonfinancial support from Menarini, outside the submitted work. Conflict of interest: M.L. Briones has nothing to disclose. Conflict of interest: O. Rajas has nothing to disclose. Conflict of interest: J. Freixinet has nothing to disclose. Conflict of interest: L. Lorente has nothing to disclose. Conflict of interest: A. Payeras has nothing to disclose. Conflict of interest: J. Ferreres has nothing to disclose. Conflict of interest: N. Carbonell has nothing to disclose. Conflict of interest: N. González-Quevedo has nothing to disclose. Conflict of interest: J.M. González-Martin has nothing to disclose. Conflict of interest: F. Rodríguez de Castro has nothing to disclose. Conflict of interest: C. Rodríguez-Gallego has nothing to disclose., (Copyright ©ERS 2021.)
- Published
- 2021
- Full Text
- View/download PDF